HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Web Marketing Up, But J&J/Motrin “Baby Sling” Ad Reveals Potential Perils

This article was originally published in The Rose Sheet

Executive Summary

Some companies are turning to Internet advertising as a source of strength in the challenging economic environment; however, consumer umbrage at an online ad for Johnson & Johnson's Motrin pain relief illustrates the gamble implicit in using online advertising to target select demographics

You may also be interested in...



Dentek Promotes Flossing With Rap Parody By YouTube Performers

Prestige Brands' Dentek oral care brand hires a family who are YouTube performers to promote its floss picks in a 30-second rap parody promoting a 30-day family floss challenge, which will invite consumers to post photos on Facebook, Instagram and Twitter.

Dentek Promotes Flossing With Rap Parody By YouTube Performers

Prestige Brands' Dentek oral care brand hires a family who are YouTube performers to promote its floss picks in a 30-second rap parody promoting a 30-day family floss challenge, which will invite consumers to post photos on Facebook, Instagram and Twitter.

Dentek Promotes Flossing With Rap Parody By YouTube Performers

Prestige Brands' Dentek oral care brand hires a family who are YouTube performers to promote its floss picks in a 30-second rap parody promoting a 30-day family floss challenge, which will invite consumers to post photos on Facebook, Instagram and Twitter.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015830

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel